Organogenesis Holdings Inc. Announces Fourth Quarter 2024 Financial Results: Detailed Report
Organogenesis Holdings Inc.: Q4 and Full Year 2024 Financial Results Canton, MA, February 27, 2025 – Organogenesis Holdings Inc., a pioneering company in the regenerative medicine and tissue innovations sector, recently announced its financial results for the fourth quarter and the year ended December 31, 2024. The company’s focus lies in the development, manufacturing, and…